Now showing items 1-4 of 4

    • Echeverría, Francisca; Valenzuela, Rodrigo; Bustamante, Andrés; Álvarez, Daniela; Ortiz, Macarena; Soto-Alarcon, Sandra A.; Jorquera Muñoz, Patricio; Corbari, Alicia; Videla Cabrera, Luis (2018)
      Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present time. For this purpose, the effect of combined eicosapentaenoic acid (EPA; 50 mg/kg/day) modulating hepatic lipid metabolism ...
    • Echeverría, Francisca; Valenzuela, Rodrigo; Bustamante, Andrés; Álvarez, Daniela; Ortiz, Macarena; Soto Alarcón, Sandra; Muñóz, Patricio; Corbari, Alicia; Videla Cabrera, Luis (Hindawi, 2018)
      Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present time. For this purpose, the effect of combined eicosapentaenoic acid (EPA; 50 mg/kg/day) modulating hepatic lipid metabolism ...
    • Videla Cabrera, Luis; Vargas, Romina; Valenzuela, Rodrigo; Muñoz, Patricio; Corbari, Alicia; Hernandez-Rodas, María C. (Churchill Livingstone, 2019)
      © 2018 Supplementation with omega-3 fatty acids or thyroid hormone (T3) exhibit negative effects on inflammatory reactions in experimental animals. The aim of this work was to assess the hypothesis that docosahexaenoic ...
    • Jaramillo, Ángela M.; Garmendia Miguel, MarÍa Luisa; Muñoz, Patricio; Corbari, Alicia; Valenzuela, Rodrigo; Casanello, Paola (Wiley, 2020)
      The interest in the amount of polyunsaturated fatty acids (PUFA) in the umbilical cord blood (UCB) is increasing, but the stability of erythrocyte PUFA in these samples during storage and washing of the erythrocytes has ...